Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...

Itch Relief Basics MISSION, KS--(Marketwire - Aug 16, 2012) - (Family Features) From bug bites and dry skin to poison ivy and chronic skin conditions, itching makes life very uncomfortable. And it's an annoyance that...